Page 107 - MEMOCibersam014

in negative symptoms and functional outcome after a new generation cognitive remediation pro- gram: A randomized controlled trial . Schizophrenia Bulletin, 40(3): 707-715 . 2014 . F .I .: 8,6070 .
33 . O’Donnell P ., Do K .Q ., Arango C . Oxidative/nitrosative stress in psychiatric disorders: Are we there yet? . Schizophrenia Bulletin, 40(5): 960-962 . 2014 . F .I .: 8,6070 .
34 . Kwapil TR, Barrantes-Vidal N . Schizotypy: Looking Back and Moving Forward . Schizophrenia bu- lletin, 2014 . Epub 2014 Dec 29 . F .I: 8,6070 .
35 . Fleischhacker W .W ., Arango C ., Arteel P ., Barnes T .R .E ., Carpenter W ., Duckworth K ., Galderisi S ., Halpern L ., Knapp M ., Marder S .R ., Moller M ., Sartorius N ., Woodruff P . Schizophrenia-Time to commit to policy change . Schizophrenia Bulletin, 40(SUPPL . 3) . 2014 . F .I .: 8,6070 .
36 . Debbané M, Barrantes-Vidal N . Schizotypy From a Developmental Perspective . Schizophrenia bu- lletin, 2014 . Epub 2014 Dec 29 . F .I: 8,6070 .
37 . Arango C ., Fraguas D ., Parellada M . Differential neurodevelopmental trajectories in patients with early-onset bipolar and schizophrenia disorders . Schizophrenia Bulletin, 40(Suppl . 2) . 2014 . F .I .: 8,6070 .
38 . Cano-Colino M ., Almeida R ., Gomez-Cabrero D ., Artigas F ., Compte A . Serotonin regulates per- formance nonmonotonically in a spatial working memory network . Cerebral Cortex, 24(9): 2449- 2463 . 2014 . F .I .: 8,3050 .
39 . Ibanez K ., Boullosa C ., Tabares-Seisdedos R ., Baudot A ., Valencia A . Molecular Evidence for the Inverse Comorbidity between Central Nervous System Disorders and Cancers Detected by Trans- criptomic Meta-analyses . PLoS Genetics, 10(2) . 2014 . F .I .: 8,1670 .
40 . Sanchez-Mora C ., Ramos-Quiroga J .A ., Bosch R ., Corrales M ., Garcia-Martinez I ., Nogueira M ., Pagerols M ., Palomar G ., Richarte V ., Vidal R ., Arias-Vasquez A ., Bustamante M ., Forns J ., Gross- Lesch S ., Guxens M ., Hinney A ., Hoogman M ., Jacob C ., Jacobsen K . Case–Control Genome-Wide Association Study of Persistent Attention-Deficit Hyperactivity Disorder Identifies FBXO33 as a Novel Susceptibility Gene for the Disorder . Neuropsychopharmacology, 2014 . [Epub ahead of print] . F .I .: 7,8330 .
41 . Bhattacharyya S, Falkenberg I, Martin-Santos R, Atakan Z, Crippa JA, Giampietro V, Brammer M, McGuire P . Cannabinoid Modulation of Functional Connectivity within Regions Processing Attentional Salience . Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2014 . [Epub ahead of print] . F .I: 7,8330 .
42 . Radua J ., Grau M ., Van Den Heuvel O .A ., Thiebaut De Schotten M ., Stein D .J ., Canales-Rodriguez E .J ., Catani M ., Mataix-Cols D . Multimodal voxel-based meta-analysis of white matter abnorma- lities in obsessive-compulsive disorder . Neuropsychopharmacology, 39(7): 1547-1557 . 2014 . F .I .: 7,8330 .
43 . Jimenez-Sanchez L ., Campa L ., Auberson Y .P ., Adell A . The Role of GluN2A and GluN2B Subunits on the Effects of NMDA Receptor Antagonists in Modeling Schizophrenia and Treating Refractory Depression . Neuropsychopharmacology, 39(11):2673-80, 2014 . F .I .: 7,8330 .
44 . Corrales A ., Vidal R ., Garcia S ., Vidal V ., Martinez P ., Garcia E ., Florez J ., Sanchez-Barcelo E .J ., Martinez-Cue C ., Rueda N . Chronic melatonin treatment rescues electrophysiological and neuro- morphological deficits in a mouse model of Down syndrome . Journal of Pineal Research, 56(1): 51-61 . 2014 . F .I .: 7,8120 .
45 . Sanchez C ., Asin K .E ., Artigas F . Vortioxetine, a novel antidepressant with multimodal activity: Review of preclinical and clinical data . Pharmacology and Therapeutics, 2014 . [Epub ahead of print] . F .I .: 7,7450 .
46 . Via E ., Zalesky A ., Sanchez I ., Forcano L ., Harrison B .J ., Pujol J ., Fernandez-Aranda F ., Menchon
www.cibersam.es 107